Kynurenic acid: translational perspectives of a therapeutically targetable gliotransmitter
Neuropsychopharmacology
.
2024 Jan;49(1):307-308.
doi: 10.1038/s41386-023-01681-6.
Authors
Ana Pocivavsek
1
,
Sophie Erhardt
2
Affiliations
1
Department of Pharmacology, Physiology, and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA. ana.pocivavsek@uscmed.sc.edu.
2
Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
PMID:
37500723
PMCID:
PMC10700309
DOI:
10.1038/s41386-023-01681-6
No abstract available
Publication types
News
MeSH terms
Kynurenic Acid*
Substances
Kynurenic Acid
Grants and funding
P50 MH103222/MH/NIMH NIH HHS/United States
R21 AG080335/AG/NIA NIH HHS/United States